版本:
中国

BRIEF-BioDelivery Sciences announces approval of BUNAVAIL

May 2 Biodelivery Sciences International Inc

* Biodelivery sciences announces the approval of bunavail® for induction of buprenorphine treatment for opioid dependence

* Biodelivery sciences international - fda approved snda for bunavail revising indication to include use of bunavail for initiation of buprenorphine treatment for opioid dependence Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐